Combination of pyrimidylaminobenzamide compounds and imatinib for treating gastrointestinal stromal tumours

摘要

The invention provides a pharmaceutical combination comprising:a) a pyrimidylaminobenzamide compound, andb) imatinib.and a method for treating or preventing a proliferative disease, especially GIST, using such a combination.